Author

Marit Scheistrøen

Observed names: M Scheistrøen, M. Scheistroen, Marit Scheiströen

Observed institutions: University Hospital of North Norway, Uppsala University Hospital, University of Oslo, Oulu University Hospital, Helsinki University Hospital, Nordland Hospital Trust, Rigshospitalet, Vejle Sygehus, Tampere University Hospital, Bristol-Myers Squibb (Sweden)

OpenAlex ID: A5029237342

Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients

1995 · Marit Scheistrøen, Claes Tropé, et al. · Cancer · 85

Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer

1992 · Ignace Vergote, Anna Himmelmann, et al. · Gynecologic Oncology · 70

First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

2003 · G. B. Kristensen, I. Vergote, et al. · International Journal of Gynecological Cancer · 53

Surgical management of stage I and II vulvar cancer: The role of the sentinel node biopsy. Review of literature

2001 · A. P. H. Makar, M. Scheistroen, et al. · International Journal of Gynecological Cancer · 51

Combined Bleomycin and Irradiation in Preoperative Treatment of Advanced Squamous Cell Carcinoma of the Vulva

1993 · Marit Scheiströen, Claes Tropé · Acta Oncologica · 49

PDF

p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas

2004 · Synne Knopp, Tone Bjørge, et al. · Gynecologic Oncology · 45

DNA Ploidy and Expression of p53 and C-erbB-2 in Extramammary Paget's Disease of the Vulva

1997 · Marit Scheistrøen, Claes Tropé, et al. · Gynecologic Oncology · 31

Cytogenetic characterization of tumors of the vulva and vagina

2003 · Francesca Micci, Manuel R. Teixeira, et al. · Genes Chromosomes and Cancer · 28

Malignant Melanoma of the Vulva FIGO Stage I: Evaluation of Prognostic Factors in 43 Patients with Emphasis on DNA Ploidy and Surgical Treatment

1996 · Marit Scheistrøen, Claes Tropé, et al. · Gynecologic Oncology · 23

Kallikrein 4 Expression Is Up-Regulated in Epithelial Ovarian Carcinoma Cells in Effusions

2005 · Ben Davidson, Zhijun Xi, et al. · American Journal of Clinical Pathology · 22

Long-term results from a phase II study of single agent paclitaxel (Taxol®) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience

1998 · C. Tropé, Th. Hogberg, et al. · Annals of Oncology · 22

Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991.

2002 · M Scheistrøen, J M Nesland, et al. · PubMed · 19

First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin (TEC) vs paclitaxel/carboplatin (TC). Interim results of an NSGO-EORTC-NCIC CTG Gynaecological Cancer Intergroup phase III trial

2002 · Gunnar B. Kristensen, Ignace Vergote, et al. · 16

[Surgery and sentinel node examination in early vulvar cancer].

2001 · C Tropé, M Scheistrøen, et al. · PubMed · 2

Focal regeneration of irradiated bone marrow: a pitfall in MR imaging.

1995 · H H Lien, I Taksdal, et al. · American Journal of Roentgenology · 2

[Endometrial hyperplasia--diagnosis and treatment].

1999 · C G Tropé, C Marth, et al. · PubMed · 1

[Laser treatment of premalignant diseases of the uterine cervix. Experiences from a central hospital].

1992 · M Scheistrøen · PubMed · 1

Short stricture of the rectum regressing on discontinuation of hormone replacement therapy: Endoscopic appearance, multiple biopsies and clinical improvement insufficient for diagnosis

2005 · Geir Hoff, Johan Wiig, et al. · Scandinavian Journal of Gastroenterology

Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer

1993 · I. Vergote, A. Himmelmann, et al. · International Journal of Gynecology & Obstetrics

[Primary amenorrhea, gonadal dysgenesis and gonadoblastoma].

1983 · A Foerster, M Scheistrøen, et al. · PubMed

Works count: 20

Citation count: 520

H-index: 13

I10-index: 13